The trend: Half of oncologists say their patients are using AI tools for information before, during, and after diagnosis and treatment, according to an August 2025 survey from Impiricus and Klick Health. The survey queried 1,000 US oncologists who are in Impiricus’ network of SMS opted-in oncologists.
Digging into the data: 50% of oncologists say they’ve noticed patients using AI tools like ChatGPT at some point in their cancer journey.
Zooming out: About one in four (38%) oncologists think AI creates patient confusion and distrust challenges for them.
Few oncologists are using AI themselves in their practices. Just 16% indicated they or their colleagues are increasing AI use.
Why it matters: Consumers' use of AI for healthcare information is growing, but healthcare providers have to contend with AI-fueled misinformation or disinformation.
What it means for pharma marketers: As patients adopt more AI for health information, pharma marketers have a growing opportunity to help physicians navigate the new dynamic.
Marketers can offer physicians training on how to discuss and correct AI-generated information, and by providing credible, easy-to-understand resources grounded in evidence. Understanding how patients use AI—from researching symptoms to evaluating treatments—can help physicians and marketers anticipate confusion, close information gaps, and strengthen trust.
You've read 0 of 2 free articles this month.
One Liberty Plaza9th FloorNew York, NY 100061-800-405-0844
1-800-405-0844sales@emarketer.com